Value, Access, and Regulatory Strategy Conference

pharmafile | September 4, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, London, Regulatory Strategy, access, dia 

Tuesday, October 09, 2018 – Wednesday, October 10, 2018
Renaissance London Heathrow Hotel, UK
See Map

Learn more about the event here
Register for the event here

Event Type: Conference

Europe is facing challenging discussions related to affordability and patient access. Ongoing collaboration activities between national HTAs and between HTAs and Regulators hold some promise for better alignment of requirements that will allow more predictable assessment outcomes in Europe. Stakeholders have started to dialogue across disciplines and legislators are proposing new instruments to set up a sustainable system for EU collaboration on clinical value assessments.

“DIA’s Value, Access, and Regulatory Strategy Conference provides the only forum for open, interactive dialogue between policy makers, payers, HTA bodies, and other stakeholders, for discussing short-term strategies and long-term market solutions.” Solange Corriol-Rohou, DrMed, Md, PhD, Senior Director, Speaker at the event, Global Regulatory Affairs & Policy, Europe, AstraZeneca, Global Medicines Development, France

Related Content

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has …

FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May

Act now! The early bird deal for FlyPharma Vienna closes on 24 May. Contact Angela …


MSD unveils plans for $1.3bn central London research centre

MSD has lifted the lid on plans to build a $1.3 billion research centre in …

Latest content